These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 19706339)

  • 1. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
    Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of aerosol administration of a sulfidopeptide leukotriene antagonist on bronchoconstriction induced by antigen inhalation in guinea pigs.
    Bando T; Fujimura M; Shintani H; Saito M; Kurashima K; Nishi K; Matsuda T
    Arzneimittelforschung; 1994 Jun; 44(6):754-7. PubMed ID: 8053975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs.
    Ishimura M; Suda M; Morizumi K; Kataoka S; Maeda T; Kurokawa S; Hiyama Y
    Br J Pharmacol; 2008 Feb; 153(4):669-75. PubMed ID: 18037905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions among three classes of mediators explain antigen-induced bronchoconstriction in the isolated perfused and ventilated guinea pig lung.
    Sundström E; Låstbom L; Ryrfeldt A; Dahlén SE
    J Pharmacol Exp Ther; 2003 Oct; 307(1):408-18. PubMed ID: 12954791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
    Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
    Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
    Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antileukotriene treatment and allergic rhinitis-related cough in guinea pigs.
    Brozmanova M; Plevkova J; Bartos V; Plank L; Tatar M
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():21-30. PubMed ID: 16204773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of inhaled KP-496, a novel dual antagonist for cysteinyl leukotriene receptor and thromboxane A(2) receptor, on allergic asthmatic responses in guinea pigs.
    Suda M; Okuda T; Ishimura M; Kurokawa S; Tokuoka S; Nakamura T; Takahashi Y; Tanaka H; Nagai H
    Pharmacology; 2009; 84(4):249-56. PubMed ID: 19776661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
    Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous effect of leucotriene CysLT1 receptor antagonists on antigen-induced motor and inflammatory responses in guinea-pig airways.
    Alfieri AB; Tramontana M; Cialdai C; Lecci A; Giuliani S; Crea A; Manzini S; Maggi CA
    Auton Autacoid Pharmacol; 2007 Jan; 27(1):39-46. PubMed ID: 17199874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.
    Kazani S; Sadeh J; Bunga S; Wechsler ME; Israel E
    Respir Med; 2011 May; 105(5):667-73. PubMed ID: 21169002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
    Ferrari F; Mennuni L; Caselli G; Zanelli T; Makovec F
    Eur J Pharmacol; 2004 Nov; 504(3):223-33. PubMed ID: 15541426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell mediators cause early allergic bronchoconstriction in guinea-pigs in vivo: a model of relevance to asthma.
    Riley JP; Fuchs B; Sjöberg L; Nilsson GP; Karlsson L; Dahlén SE; Rao NL; Adner M
    Clin Sci (Lond); 2013 Dec; 125(11):533-42. PubMed ID: 23799245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
    Bronsky EA; Kemp JP; Zhang J; Guerreiro D; Reiss TF
    Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.